Code Clarity30 Loka 2025

S5 E4: Strictly Compliance: The Med Ed Slowdown

It seems the PMCPA's review on defining Medical Education is freezing up ❄️. With the PMCPA’s influence possibly shaping European guidance, and post-Brexit UK now charting its own stricter course, is this the moment to rethink how “medical education” and “promotion” are defined, and what it means for pharma on both sides of the Channel?

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(92)

4. Be safe when it comes to safety info

Rina and Jean discuss a PMCPA case for Daiichi-Sankyo (Case AUTH/3627/4/22 ), and we ask how much safety info should patient booklets contain?

27 Heinä 20234min

3. The puzzlement of supplements

Rina and Jean discuss a PMCPA case about a Novartis promotional supplement on a third-party website (Case AUTH/3626/3/22), which was shared via email...

27 Heinä 20233min

2. Pop-up to slow down...

Code Clarity's Founders and ABPI Code experts, Rina Newton & Jean Woolcock discuss Allergan's ruling (AUTH/3625/3/22) and what the pharma industry could do with their website pop-ups.

18 Heinä 20233min

1. Don't stop using LinkedIn!

Code Clarity's Founders (Rina Newton & Jean Woolcock) chat about how compliance risks when using LinkedIn can be easily mitigated. Listen to our very short overview OR read full cases (available at p...

18 Heinä 20237min